Including results for novavax investor relations
Search only for nvax investor relations
Novavax, Inc. is a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases. ... Currency in USD ...
People also ask
Is Novavax a good company to invest in?
How much will Novavax make in 2024?
What is NVAX new price target?
Who is the largest shareholder of Novavax?
Investor inquiries. Shareholders seeking information can contact investor relations at (240) 268-2022 or email us at ir@novavax.com. Novavax corporate policy ...
Novavax's Investor Hub Visit our Investor Hub to access investor resources and information on upcoming and past events. Sign up to receive notifications for ...
Novavax Investor Relations - Investor alerts. Novavax creates transformational vaccines that help address some of the world's most pressing infectious diseases ...
According to Zacks Investment Research, based on 5 analysts' forecasts, the consensus EPS forecast for the quarter is $-1.04. The reported EPS for the same ...
Feb 28, 2024 · Investors Erika Schultz 240-268-2022 ir@novavax.com. Media Ali Chartan 240-720-7804 media@novavax.com. SOURCE Novavax, Inc. ×. Modal title. Also ...
Access Novavax Inc (NVAX) Investor Relations material, such as Live Earnings Calls, Transcripts, Slides, Reports, and Estimates using Quartr.